PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 107, Issue 3, Pages 491-500
Publisher
Springer Nature
Online
2012-06-22
DOI
10.1038/bjc.2012.272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pim-1 Kinase Expression Predicts Radiation Response in Squamocellular Carcinoma of Head and Neck and Is under the Control of Epidermal Growth Factor Receptor
- (2015) Katriina Peltola et al. NEOPLASIA
- PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
- (2011) C. Gomez-Abad et al. BLOOD
- Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
- (2011) Jonathan H. Schatz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- 7,8-Dichloro-1-oxo-β-carbolines as a Versatile Scaffold for the Development of Potent and Selective Kinase Inhibitors with Unusual Binding Modes
- (2011) Kilian Huber et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors
- (2010) F. Anizon et al. CURRENT MEDICINAL CHEMISTRY
- Pim kinase inhibitors: a survey of the patent literature
- (2010) Tina Morwick EXPERT OPINION ON THERAPEUTIC PATENTS
- PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
- (2010) L. Brault et al. HAEMATOLOGICA
- Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores
- (2010) Alexandar Tzankov et al. LEUKEMIA & LYMPHOMA
- Pim-1 Kinase Protects P-Glycoprotein from Degradation and Enables Its Glycosylation and Cell Surface Expression
- (2010) Y. Xie et al. MOLECULAR PHARMACOLOGY
- Activation of the Wnt Pathway Plays a Pathogenic Role in Diabetic Retinopathy in Humans and Animal Models
- (2009) Ying Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas
- (2009) Sabine Nagel et al. EXPERIMENTAL HEMATOLOGY
- BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma
- (2009) E C Obermann et al. JOURNAL OF CLINICAL PATHOLOGY
- Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment
- (2009) E C Obermann et al. JOURNAL OF CLINICAL PATHOLOGY
- Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration
- (2009) Rebekka Grundler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas
- (2009) Cecile Meier et al. MODERN PATHOLOGY
- PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis
- (2009) J J Gu et al. ONCOGENE
- Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
- (2009) S. Hailfinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
- (2008) D. Morishita et al. CANCER RESEARCH
- Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
- (2008) A. Tzankov et al. HAEMATOLOGICA
- Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study
- (2008) Eric D. Hsi et al. LEUKEMIA & LYMPHOMA
- Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2
- (2008) Thomas Fischer et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started